Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009

Overview of the 2010 work programme

Paul Griffiths, Roland Simon, Rosemary de Sousa

Scientific Committee meeting, Lisbon, November 2009

Overview

• Three-year strategy (2010–2012) will be implemented through three annual work plans, 2010 WP is the first

• Heart of the agency work remains:• State-of-the-art review of the drug phenomenon• Maintaining online reference point on drugs• Providing ongoing support to for implementation and monitoring of the

EUAP• 2010 highlights:

• Ensuring data quality and joined analytical approaches• Increase transversal work (CUPs)• Establishment of EU guidelines framework and standards• Improve detection and exchange on emerging trends• Improve monitoring of drug supply and supply reduction activities• Methodological developments (KIs, pubic expenditures, monitoring

responses)• Dissemination and valorisation of EMCDDA products and findings

Established systems: consolidate, improve, implement

Developmental areas: in-depth analysis, testing, consensus building

Modelling

Drug treatment

Drug use in prison settings

Drug supply and supply reduction

Monitoring drug situation New trends and development

Monitoring responses to drugs

Best practices, standards and guidelines

WP schematic

Main activities

2010 work programme – main activities

• Monitoring the drug situation

• New trends and development

• Monitoring responses

• Best practices, standards and guidelines

• Tools and processes

• Key Indicators• Developmental

areas• Innovative

strategies

• More efficient data processing

• Qualitative data in SB

• State of the art (AR)








areas• Innovative

strategies

• Promote tools and expert network

• Finalise TDI review• Revise mortality cohort

protocol• Develop alternative

estimates of PDU• Finalise DRID protocol








areas• Innovative

strategies

• Polydrug use and vulnerable groups

• Crime and market








areas• Innovative

strategies

• Treatment coverage day

• Drug consumption estimates

• Decentralised data system (data lab.)

• Incidence of drug use






• Implementation of EWS

• Emerging trends

• Effective implementation of Council decision

• Develop Forensic network

• Conceptualisation monitoring internet

• Strengthen collaboration (Europol, EMEA…)






• Availability, accessibility and characteristics of responses

• Set of response indicators

• Developmental areas

• Tools for non-opiates related problems

• Use and potential of expert ratings

• Environmental prevention strategies

• Fine-tune ST public expenditure






• Availability, accessibility and characteristics. of responses



• Comprehensive model

• Availability, coverage of interventions

• Economic analysis of drug markets

• Better cover treatment in prison






• Availability, accessibility and characteristics. of responses



• Drug policy harm indexes

• Alcohol-cannabis interactions

• Public expenditure focus on prisons

• Economic modelling






• Tools to assess drug policies

• Good practices, guidelines and quality standards

• EU guidelines for evaluation

• Cost of drug- related treatment

• Restructure ELDD• 1st progress

review (EUAP)






• Tools to assess drug policies

• Good practices, guidelines and quality standards

• Further develop best practices portal: HR

• Develop and contribute to EU level guidelines and benchmarks

Cross-unit projects

2010 work programme – Cross-unit projects

• Treatment• DSSR• Prison• Modelling

• Further develop and implement treatment data collection strategy

• Improve estimates of treatment coverage

• Improve modelling of service provision vs needs



• Mini conference on price, purity, supply reduction activities, new trends

• Further deepen collaboration with EUROPOL

• Expert working group on DSSR• Combined price purity indicator



• Review current data collection• Review and relaunch WHO prison

databank


• Treatment• DSSR• Prison• Modelling • Audit and review approaches

• Develop proposal for scientific monograph

Main outputs

2010 work programme – main outputs

• Annual report package

• Scientific Monograph• Insights• Selected issues• Manuals• Drug profiles• Drugs in focus• Thematic papers• Joint publications• Online tools• Articles

• Annual report• Statistical bulletin




• Harm reduction: evidence, impact and challenges




• Injecting• Treatment and care for older drug users• Problem (meth)amphetamine use




• Drug-related infectious diseases protocol• Joint manual for drug information systems• EU evidence-based standards for drug

prevention




• EU’s information needs for effective drug policies

• Current issues for harm reduction• Policy perspective on the use of internet

and drug use




• The EU cocaine market• The EU ecstasy market• The EU amphetamine market


• Ongoing improvement of emcdda.europa.eu

• Ongoing update of Best practice portal• European legal database on drugs (ELDD)• Country intervention profiles


• Scientific Monograph

• Insights• Selected issues• Manuals• Drug profiles• Drugs in focus• Thematic papers• Joint publications• Online tools• Articles



• Scientific Monograph

• Insights• Selected issues• Manuals• Drug profiles• Drugs in focus• Thematic papers• Joint publications• Online tools• Articles

• Comparative analysis of HCV trends• Drug-related infectious diseases modelling• Polydrug use among treated clients• Polydrug use among school children• Monitoring drug use in prison• European drug consumption• Incidence of problems drug use• Application of illicit drug analysis in the

environment• Modelling economic impact of economic

recession on drug treatment• Modelling disorganised crime: cannabis market

Questions and discussion…

Documents

Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009